10 days ago
MPLT
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Top 10%
#506 out of 5340 analysts
Average Return
+15.37%
Win Rate
62%61 out of 99
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-17 - 2024-10-16 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +137.72% | $7.82 | $18.59 | 2025-01-13 - 2025-10-28 | Strong Buy |
Axsome Therapeutics IncAXSM | +127.23% | $103.26 | $234.64 | 2025-08-06 - 2026-07-30 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-03 - 2024-01-24 | Strong Buy |
Corcept Therapeutics IncCORT | +107.29% | $57.08 | $118.32 | 2026-05-13 - 2026-07-30 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
16 days ago
AMRX
a month ago
CYTK
2 months ago
LEGN
2 months ago
JAZZ
3 months ago
CORT
3 months ago
ALKS
3 months ago
TEVA
3 months ago
RPRX
4 months ago
AXSM
7 months ago
AXSM
8 months ago
JAZZ
9 months ago
ABBV
10 months ago
NBIX
10 months ago
TEVA
2 years ago
TEVA
2 years ago
LEGN
3 years ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals IncCRNX | 2 | Hold | $85.00 | +1.64% | Downgrades | 3 days ago |
Legend Biotech CorpLEGN | 6 | Hold | $28.00 | +46.98% | Downgrades | 7 days ago |
Maplight Therapeutics IncMPLT | 2 | Strong Buy | $52.00 | +270.63% | Maintains | 10 days ago |
Amneal Pharmaceuticals IncAMRX | 2 | Strong Buy | $23.00 | +24.32% | Maintains | 16 days ago |
Exelixis IncEXEL | 6 | Hold | $52.00 | -7.09% | Maintains | a month ago |
Cytokinetics IncCYTK | 7 | Strong Buy | $115.00 | +43.00% | Upgrades | a month ago |
Incyte CorpINCY | 4 | Hold | $113.00 | -8.12% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 8 | Strong Buy | $307.00 | +18.82% | Upgrades | 2 months ago |
Corcept Therapeutics IncCORT | 2 | Strong Buy | $72.00 | -39.15% | Upgrades | 3 months ago |
Alkermes PLCALKS | 5 | Strong Buy | $48.00 | -4.06% | Maintains | 3 months ago |
Teva Pharmaceutical Industries LtdTEVA | 11 | Strong Buy | $42.00 | +18.61% | Maintains | 3 months ago |
Royalty Pharma PLCRPRX | 5 | Strong Buy | $57.00 | -3.42% | Maintains | 3 months ago |
Axsome Therapeutics IncAXSM | 8 | Strong Buy | $259.00 | +10.38% | Maintains | 4 months ago |
AlvotechALVO | 2 | Strong Buy | $6.00 | +68.07% | Maintains | 4 months ago |
United Therapeutics CorpUTHR | 12 | Strong Buy | $705.00 | +34.08% | Maintains | 5 months ago |
Harmony Biosciences Holdings IncHRMY | 4 | Hold | $46.00 | +28.28% | Downgrades | 6 months ago |
Neurocrine Biosciences IncNBIX | 11 | Strong Buy | $178.00 | -4.04% | Maintains | 6 months ago |
Insmed IncINSM | 1 | Strong Buy | $215.00 | +111.84% | Maintains | 7 months ago |
Acadia Pharmaceuticals IncACAD | 9 | Strong Buy | $40.00 | +50.66% | Maintains | 7 months ago |
Biohaven LtdBHVN | 5 | Hold | $11.00 | -20.41% | Downgrades | 8 months ago |
Abbvie IncABBV | 1 | Hold | $220.00 | -14.53% | Maintains | 9 months ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Hold | $20.00 | -7.58% | Downgrades | 9 months ago |
Immunovant IncIMVT | 1 | Hold | $18.00 | N/A | Maintains | a year ago |
Coherus Oncology IncCHRS | 5 | Hold | $1.05 | N/A | Maintains | a year ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | N/A | Maintains | 2 years ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | N/A | Maintains | 2 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 4 years ago |
Viatris IncVTRS | 2 | Hold | $12.00 | N/A | Upgrades | 4 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.